Literature DB >> 9404482

Apoptosis as a cell biological abnormality in myelodysplasia.

Y Yoshida1, H Kawabata, N Anzai, K Tohyama.   

Abstract

Evidence is accumulating to indicate that alterations in the control of apoptosis can contribute to a variety of disorders. Among the disorders associated with abnormal regulation of apoptosis, MDS stands out unequaled in that apoptosis is related, in apparently opposite directions, to ineffective hematopoiesis and leukemic transformation of MDS; notably, excessive apoptosis in the former and deranged apoptosis or escape from apoptotic control in the latter. In this review, we want to focus on the role of apoptosis in various stages of MDS, and to discuss its possible relevance to further therapeutic interventions.

Entities:  

Mesh:

Year:  1997        PMID: 9404482

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  2 in total

1.  Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes.

Authors:  Naho Nagashima; Masaharu Hisasue; Katsumi Higashi; Rui Kano; Hajime Tsujimoto; Atsuhiko Hasegawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

2.  Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome.

Authors:  Yuekun Qi; Xiao Li; Chunkang Chang; Feng Xu; Qi He; Youshan Zhao; Lingyun Wu
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.